F543-0465 Screening compound: 4-methyl-N-{1-[3-(2-oxo-1-propyl-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]ethyl}benzene-1-sulfonamide

F543-0465 Screening compound: 4-methyl-N-{1-[3-(2-oxo-1-propyl-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]ethyl}benzene-1-sulfonamide
F543-0465 Screening compound: 4-methyl-N-{1-[3-(2-oxo-1-propyl-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]ethyl}benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F543-0465
4-methyl-N-{1-[3-(2-oxo-1-propyl-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]ethyl}benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F543-0465

Molecular Formula

C21H23N5O4S (C21 H23 N5 O4 S)

Compound Name

4-methyl-N-{1-[3-(2-oxo-1-propyl-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]ethyl}benzene-1-sulfonamide

IUPAC name

4-methyl-N-{1-[3-(2-oxo-1-propyl-23-dihydro-1H-13-benzodiazol-5-yl)-124-oxadiazol-5-yl]ethyl}benzene-1-sulfonamide

SMILES

CCCN(c(ccc(-c1noc(C(C)NS(c2ccc(C)cc2)(=O)=O)n1)c1)c1N1)C1=O

InChI

InChI=1S/C21H23N5O4S/c1-4-11-26-18-10-7-15(12-17(18)22-21(26)27)19-23-20(30-24-19)14(3)25-31(28,29)16-8-5-13(2)6-9-16/h5-10,12,14,25H,4,11H2,1-3H3,(H,22,27)/t14-/m0/s1

InChI Key

OANJQOWZVABPNG-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD27175208

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.51

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.979

Distribution Coefficient, logD

4.893

Water Solubility, LogSw

-4.55

Polar Surface Area

100.124

Acid Dissociation Constant (pKa)

8.06

Base Dissociation Constant (pKb)

-0.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.60

F543-0465 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F543-0465 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F543-0465?
Check Price and Availability of F543-0465, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F543-0465 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F543-0465
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F543-0465
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F543-0465 available by request